Loading...
XAMSCRBN
Market cap1.28bUSD
Dec 20, Last price  
21.38EUR
1D
-0.65%
1Q
-9.33%
Jan 2017
-15.93%
Name

Corbion NV

Chart & Performance

D1W1MN
XAMS:CRBN chart
P/E
16.82
P/S
0.85
EPS
1.27
Div Yield, %
2.70%
Shrs. gr., 5y
0.13%
Rev. gr., 5y
9.98%
Revenues
1.44b
-0.97%
2,731,700,0002,391,600,0002,421,400,0002,485,600,0002,599,300,0002,555,900,0002,990,100,0003,112,600,000753,700,000743,600,000770,100,000918,300,000911,300,000891,700,000897,200,000976,400,000986,500,0001,070,800,0001,457,900,0001,443,800,000
Net income
73m
-19.00%
159,700,000423,400,000104,700,000202,800,00090,000,00086,800,00099,300,000-174,300,000-63,700,0002,400,000-20,700,00080,200,000103,600,00084,600,00054,300,00025,800,00073,100,00078,300,00090,000,00072,900,000
CFO
165m
+210.90%
200,100,000833,000,000177,800,000138,800,00098,500,000277,200,000188,600,000148,000,000197,400,0009,900,00066,800,000110,300,000122,600,000117,700,00099,500,000115,700,000113,400,00026,700,00053,200,000165,400,000
Dividend
May 19, 20240.61 EUR/sh
Earnings
Feb 21, 2025

Profile

Corbion N.V. provides lactic acid and lactic acid derivatives, emulsifiers, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide. The company offers ingredient solutions made from renewable resources for the food, home and personal care, pharmaceutical, animal nutrition, medical device, and bioplastics markets. It markets its products through a network of sales offices and distributors. The company was formerly known as CSM N.V. and changed its name to Corbion N.V. in October 2013. Corbion N.V. was founded in 1919 and is headquartered in Amsterdam, the Netherlands.
URL
http://www.corbion.com/
IPO date
Jan 04, 1999
Employees
2,601
Domiciled in
NL
Incorporated in
NL

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,443,800
-0.97%
1,457,900
36.15%
1,070,800
8.55%
Cost of revenue
1,321,400
1,352,000
1,025,500
Unusual Expense (Income)
NOPBT
122,400
105,900
45,300
NOPBT Margin
8.48%
7.26%
4.23%
Operating Taxes
12,400
26,400
8,200
Tax Rate
10.13%
24.93%
18.10%
NOPAT
110,000
79,500
37,100
Net income
72,900
-19.00%
90,000
14.94%
78,300
7.11%
Dividends
(33,100)
(33,000)
(33,000)
Dividend yield
2.86%
1.74%
1.34%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
368,500
322,000
84,600
Long-term debt
481,900
437,200
418,600
Deferred revenue
12,900
61,200
59,500
Other long-term liabilities
29,900
19,800
22,000
Net debt
695,500
606,400
365,900
Cash flow
Cash from operating activities
165,400
53,200
26,700
CAPEX
(149,300)
(235,800)
(148,700)
Cash from investing activities
(146,800)
(213,300)
(123,700)
Cash from financing activities
(5,300)
173,900
85,900
FCF
128,700
(271,000)
(164,200)
Balance
Cash
70,200
58,200
42,200
Long term investments
84,700
94,600
95,100
Excess cash
82,710
79,905
83,760
Stockholders' equity
555,400
570,500
498,900
Invested Capital
1,368,890
1,322,695
993,840
ROIC
8.17%
6.86%
4.19%
ROCE
8.27%
7.30%
4.04%
EV
Common stock shares outstanding
59,700
59,500
59,400
Price
19.38
-39.13%
31.84
-23.17%
41.44
-10.21%
Market cap
1,156,986
-38.93%
1,894,480
-23.04%
2,461,536
-10.36%
EV
1,852,486
2,500,880
2,827,436
EBITDA
207,000
178,600
106,100
EV/EBITDA
8.95
14.00
26.65
Interest
29,700
17,400
11,500
Interest/NOPBT
24.26%
16.43%
25.39%